Skip to main content

Miller Laurie A.'s Form 4 filing

Haemonetics CorpHAE · filed May 18, 2022

Accession no.
0001127602-22-014990
Filed
May 18, 2022
Trade date
May 16, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.74K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Miller Laurie A.CIK 0001881751Officer (SVP, Human Resources)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
May 16, 2022Common StockSSaleDisposed−31$56.10−$1,739.110,232Direct
May 16, 2022Common StockAGrant or awardAcquired+3,038–F4–13,270Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
May 16, 2022Common StockAGrant or awardAcquired+7,104$0.00$07,104Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F4

Each RSU represents a contingent right to receive one (1) share of the Issuer's common stock when vested.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)